Even though the number of new diagnoses each year is trending down, diabetes is still a prevalent chronic disease in the United States. If left unchecked, one person out of every three will be diabetic by the time millennials collect Social Security.
In 2017, how people shop, why people shop and what they’re shopping for will all be shaped by two overarching themes — access to digitized health information and wearables, as well as other Bluetooth-enabled, diagnostic-style self-care offerings.
There are definitely several themes playing out across Drug Store News’ top 10 list of breakthrough brands, defined by those brands that have contributed the most impactful growth over an annualized period, in this case for the 52 weeks ended Oct. 2 across total U.S. multi-outlets, according to IRI.
Univision Communications Inc., in partnership with Nielsen, in October took a deep dive into how Hispanics buy and shop the self-care aisles. They are an important demographic for OTC purveyors — they have larger households than average; they’re more brand loyal; and they’re not only younger than the average American, but also have a longer life expectancy.
Sales of OTC medicines continued on a strong growth trajectory of more than 3%, growing by approximately $1.4 billion in dollar volume to $45.6 billion for the 52 weeks ended Oct. 2, according to IRI data. And that’s primarily organic growth from existing brands.
First order of business for Veru's new VP marketing will be to oversee the roll-out of FC2 as a prescription product, including establishing the infrastructure necessary for facilitating reimbursement under the Affordable Care Act.
Until now, it was believed that previous exposure to a flu virus conferred little or no immunological protection against new influenza viruses that can jump from animals into humans. That is no longer the case.